Objective: To fine out fatigue frequency and severity by FACIT-F scale in Pakistani cohort
with rheumatoid arthritis. Methods: This study was conducted at department of Medicine …

Objective To generate initial data on the frequency and effect of symptomatic adverse events
(AEs) associated with rheumatoid arthritis (RA) drug therapy from the patient perspective …

Purpose Using data from real-world practice, this analysis compared outcomes in patients
with rheumatoid arthritis (RA) initiating treatment with an oral Janus kinase inhibitor …

Objective The objective of this study was to compare achievement of remission in 2 early
rheumatoid arthritis (RA) treat‐to‐target (TTT) cohorts, a tight control cohort with a target of …

Introduction This systematic review and meta-analysis aimed to analyze the adherence rate
for conventional and biological disease-modifying antirheumatic drugs (DMARDs) utilizing …

Identifying factors that influence problematic beliefs and behaviors related to
pharmacotherapy may be useful for clinicians to improve the patients' adherence. The study …

Objectives Non-adherence to rheumatoid arthritis (RA) treatments must be identified. A
methotrexate (MTX) urinary dosage (METU) was recently developed. The aim of our study …

Introduction Facilitators and barriers of adherence to disease-modifying anti-rheumatic
drugs (DMARDs) have been identified by patients with inflammatory arthritis earlier …

Despite developments in pharmacological treatments, chronic fatigue is an unresolved issue
for most people with inflammatory arthritis that severely disrupts their personal and working …

Background Because effective treatment for rheumatoid arthritis (RA) is dependent on
medication use, medication optimization is critically important. Medication adherence …